{"nct_id":"NCT01522443","title":"Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer","status":"TERMINATED","status_verified_date":"2018-04","start_date":"2012-03","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-01-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["EXEL"]}